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A B S T R A C T
This article examines historical trends in the reporting of health, illness and medicine in UK and Italian news-
papers from 1984 to 2017. It focuses on the increasing “biomedicalization” of health reporting and the framing
of health and medicine as a matter of technoscientific interventions. Methodologically, we relied on two large
datasets consisting of all the health- and medicine-related articles published in the online archives of The
Guardian (UK) and la Repubblica (Italy). These articles underwent a quantitative analysis, based on topic mod-
elling techniques, to identify and analyse relevant topics in the datasets. Moreover, we developed some synthetic
indices to support the analysis of how medical and health news are “biomedicalized” in media coverage.
Theoretically, we emphasise that media represent a constitutive environment in shaping biomedicalization
processes. Our analyses show that across the period under scrutiny, biomedicalization is a relevant, even if
sometimes ambivalent, frame in the media sphere, placing growing centrality on three dimensions: i) health and
well-being as a matter of individual commitment to self-monitoring and self-surveillance; ii) biomedicine as a
large technoscientific enterprise emerging from the entanglement between research fields and their technolo-
gical embodiments; iii) the multiverse reforms of welfare systems in facing the trade-off between universal
health coverage and the need to render the national healthcare system more sustainable and compatible with
non-expansionary monetary policies and austerity approaches in managing state government budgets.
1. Introduction and theoretical remarks
In the late 1990s, considering the substantial technoscientific re-
shaping of contemporary biomedicine, medical sociologists questioned
some of the key assumptions of medicalization theory (Conrad, 1992,
2005, 2007), which traditionally represented one of the most sig-
nificant frameworks for scrutinizing changes in the relations between
medicine and society. In this regard, Clarke and colleagues proposed
the “biomedicalization theory”, with the aim of emphasising how, be-
ginning about 1985 (Clarke and Shim, 2011, p. 180), medicine and life
sciences start to coalesce and transform “from the inside out through
old and new social arrangements that implement biomedical, computer,
and information sciences and technologies to intervene in health, ill-
ness, healing, the organisation of medical care, and how we think about
and live life ‘itself’” (Clarke et al., 2010a, p. 2).
Biomedicalization is located within the epistemic realignment of the
“clinical gaze” (Foucault, 1973) with the “molecular gaze”, which
permeates contemporary clinical routines (Rose, 2007). The “tech-
noscientization” of medicine (Wehling, 2011) is shaping a new “bio-
politics”, encompassing circuits of vitality in which molecular entities
of life can be mobilised and arranged to open new forms of care: “op-
timisation”, “susceptibility” and “body enhancement” (Lemke, 2007;
Clarke and Shim, 2011).
Under this perspective, analytical sensitivity has turned towards the
study of new emerging possibilities for “enhancing” and “optimising”
life itself as well as the technoscientific re-organisation of biomedical
knowledge (Clarke et al., 2010b). This is a broad perspective proposing
novel analytical lenses to capture general social changes of 21st century
medicine concerning the bio-politics of life, the conditions of access to
healthcare services, the lifestyle transformations via (self)surveillance
techniques and the emergence of new bio-economies (Novas and Rose,
2000, Novas, 2006; Rabinow and Rose, 2006).
Referring primarily to the USA, Clarke and co-authors argued that
the rise of scientific medicine occurred between 1890 and 1945. In this
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period of time the US medical sector has been fully consolidated: we
need only think, for example, that even during the Great Depression,
Americans spent over $3.5 billion annually on medical services (see
Clarke and Shim, 2011, p. 179). The medicalization era covers the
period between 1940 and 1985, marking the exponentially expansion of
the medical jurisdiction within several social domains. Only since 1985
we can see the first harbinger of the major technoscientific changes in
the constitution and practices of contemporary biomedicine, which
mainly occurred in the two following decades, opening up the biome-
dicalization era, as the emerging outcome from the mutual inter-
dependence of five major trends (Clarke et al., 2003, 2010a; 2010c):
i. a political economic shift towards the constitution of the so-called
Biomedical TechnoService Complex, Inc. as a new socio-technical
form of organising and commodifying the health sector on a global
scale. Hence, the biomedical research, outcomes and services are
increasingly corporatized, rather than state-funded;
ii. a radical turn towards a proactive biomedical intervention in health
(in addition to injury, illness and disease) as well as a redefinition of
the risk and surveillance technique in biomedicine. Health is in-
creasingly conceived as a moral obligation and an individual goal,
which ought to be pursued not only through appropriate lifestyles
but also via technical means;
iii. The constitution of biomedical practices in terms of a tech-
noscientific assemblage of bytes, computerised databases, genomic
technologies and molecular entities as “actionable tools” for the
treatment and enhancement of the living body;
iv. New configurations in producing and sharing biomedical knowl-
edge across different places, especially the Internet, which reshape
the boundaries between lay and expert knowledge;
v. Transformations of living bodies and shaping of new individual
identities, fostering collective forms of bio-socialites.
Biomedicalization processes deploy a broad range of trends, in-
cluding the commodification of health, the development of new risk
forecasting models, the increasing relevance of molecular diagnostic
tests and an even closer relationship between scientific laboratories,
clinical settings and the marketplace. Body interventions are not only
performed by medical professionals but also by each of us through
“technologies of the self” (i.e. self-tracking apps; see Lupton, 2016) as a
form of self-government of health.
In their study on biomedicalization and newspapers coverage of
health and medicine, Hallin et al. (2013) argued that “these develop-
ments increase the range of social interests that are affected by and
implicated in the field of health and medicine, and thus increase both
the potential for public controversy and range of actors prepared to
intervene in it” (p. 121). Indeed, in everyday life people are exposed to
a plurality of information about health. Newspapers circumscribe an
informational landscape to their experience, promoting diverse implicit
or explicit messages on how to take care of living bodies. Thus, media
are an important resource for gaining “somatic expertise” (Rose, 2007,
p. 6), disclosing and legitimising new sub-professions (e.g. specialists in
reproductive medicine, stem cell therapists, genetic counsellors), which
act as new “pastoral experts” responsible for communicating on health
issues (Seale, 2002).
In the context of biomedicalization media play a pivotal role not
only in popularising or driving biomedicalization processes, but also in
constituting complex “healthscapes” (Clarke, 2009, 2010a) which ac-
tively intervene in producing, re-producing or contrasting these pro-
cesses. In this sense, media can be seen as layered contexts of things,
people and assumptions, contributing to co-shaping biomedicalization,
with “biomedicine as culture per se as regime of truth” (Clarke et al.,
2003, p. 163).
As highlighted by Cartwright (1998, p. 220), “medicine is a culture
field whose meanings are created not only by the elite managers of
technoscientific laboratories and research centers, but also through the
intervening forces of popular media and by media activist con-
tercultures”. Generally speaking, public narratives can shape, re-
produce and reinforce what seems possible (knowledge) and desirable
(imaginaries) as well as what seems appropriate or inappropriate
(norms, values and beliefs). Therefore, not only can media influence the
agenda of public discourses or reflect what is going on in certain bio-
medical fields; they are also influenced by social actors and relevant
stakeholders (such as policymakers, researchers, patient organisations
and NGOs) as crucial “makers” of information and meanings.
Accordingly, contemporary media are generative elements engaged in
the exchange, reproduction and transformation of the (social) meaning
of health- and medicine-related content (Altheide, 2013). Therefore,
the analysis of media can be two-fold: on one hand, media can be ob-
served as agents contributing to the development of social processes; on
the other hand, they represent a source of data for studying those
processes.
The fact that the emergence of ‘‘technoscientific biomedicine’’ re-
sulting from the intertwinement of science and technology may have
serious social and cultural impact has been debated in recent years
(Burri and Dumit, 2007). The present article explores the biomedica-
lization process, developing a comparative study concerning medical
and health accounts in la Repubblica (Italy-based newspaper) and The
Guardian (UK-based newspaper), with particular attention on the extent
to which media narratives have become “biomedicalized”. In order to
capture the variety of situations that the biomedicalization is asking to
investigate, we selected these two newspapers since they para-
digmatically exemplify diverse cultural, economic, geographic and
political contexts in Europe, also accordingly to different welfare state
models (i.e. “liberal” in UK and “Latin” in Italy, see Saint-Arnaud and
Bernard, 2003; Raphael and Bryant, 2015), to which health outcomes
are related. We are aware that these two broadsheet newspapers are not
representative of the overall media ecology existing in UK and Italy.
Even so, the fact that they are two elite newspapers makes them par-
ticularly attentive to question medical and health issues, and due to
their peculiar similarity (in news framing, in the editorial policy and
line, and in the audiences) they are undoubtedly suitable to develop a
consistent comparative analysis. Furthermore, both newspapers have a
large online available repository, which allowed us to shape a dataset
exploitable in a coherent way with the selected methodological fra-
mework. Overall, we want to address the issue of biomedicalization,
with particular reference to the European context, as an open theore-
tical and empirical issue, rather than as a taken-for-granted conclusion
about the progressive technoscientific transformation of biomedicine
“from the inside out”.
2. Methodological framework
2.1. Research questions
Our purpose is to provide an innovative understanding of the ways
in which public discourses in mainstream media may embody particular
representations of the emerging biomedicalization as a whole and, ac-
cordingly, to analyse the development of its constitutive dimensions
over time. Considering the intersection of the five key processes around
which biomedicalization is extending in our everyday experience, we
identified three interrelated analytical areas, which will orient our
comparative study.
First, we are interested in understanding how biomedicalization is
reshaping contemporary forms of governmentality (Franklin, 2000;
Prainsack, 2017) through the development of strategies of optimisation
for the healthy living body. Health and the management of chronic
illnesses are becoming individual moral responsibilities, performed via
self-surveillance techniques embedded in a “culture of life” deeply
rooted in the idea of individual perfectibility and enhancement (Knorr-
Cetina, 2005, pp. 76–77). Because of new engines aimed at the max-
imisation of health quality, biomedicalization reflects a growing
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emphasis on risk reduction and control in contemporary health and
medical discourse (Sulik, 2011). Accordingly, our first research ques-
tion (RQ1) is as follows:
To what extent does media coverage show that health and illness status
are increasingly becoming a matter of complex techno-moral perfor-
mance of technoscientific identities, implying multiplies forms of risk
(self)management?
Second, biomedicalization scholars have argued that contemporary
biomedicine is a highly technoscientific initiative. This is illustrated by
the growing intertwinement of clinics and scientific laboratories, where
the aim is to quickly introduce, in clinical routines, new diagnostics,
treatments and procedures from bioengineering, molecular biology,
genomics, proteomics, etc. (Crabu, 2016, 2018; Cambrosio et al., 2018).
Our second research question (RQ2) reads:
To what extent does media coverage portray biomedicine as a strategic
“high-tech” sector, deeply permeated by broader technoscientific in-
novation dynamics?
In connection with this broad research question, we will also ana-
lyse the molecularisation processes enacted by the growing inter-
twinement of biotechnologies, nanotechnologies, molecular biology
and clinical medicine. To do this, we ask the following more specific
sub-research question (RQ2.1):
To what extent does media coverage show a (sub)molecular (rather than
a molar) conception of life, in relation to the management of health and
illness conditions?
Third, at the core of biomedicalization theory, we found the re-
constitution of a novel bio-political economy of life. Here, we are in-
terested in exploring media accounts about the process of commodifi-
cation and corporatization of health and illness, within which new
private actors (i.e. biotechnology and pharmaceutical companies) play
a pivotal role in reconfiguring health sector governance. Our third re-
search question (RQ3) is:
To what extent does media coverage show narratives and accounts about
healthcare commodification and the emergence of corporatized and
privatised players in offering and managing healthcare services?
We argue that the combined exploration of these three substantive
areas under the three RQs can allow us to (1) verify whether and to
what extent biomedicalization processes are pervading health and
medicine narratives in the public sphere and (2) to have a more in-
depth understanding of the growing role assumed by the mainstream
press in configuring contemporary biomedicine as well as its cultural,
epistemic and bio-political authority. Addressing the above RQs is
crucial, since the on-going biomedicalization drivers ought to be ana-
lysed over time in relation to their specificities, which may vary be-
tween countries in ways that still need to be explored empirically. Thus,
following the RQs, we also aim to clarify how and to what extent bio-
medicalization and media are mutually interlaced, highlighting how
biomedicalization processes are co-constituted via specific discursive
moves acted out in the public sphere, assuming the press as a proxy
(Neresini and Lorenzet, 2016).
2.2. Data analysis
Our analysis is based on two large datasets of all the health- or
medicine-related articles found in the public archives of la Repubblica
and The Guardian. These articles were analysed using quantitative
techniques, namely through both a manual and iterative analysis of
topics extracted by Latent Dirichlet Allocation (LDA; see Blei et al.,
2003).1
The article selection was performed by searching the public archives
of The Guardian and la Repubblica from 1984 to 2017, using the key-
words “health OR medicine” [“salute OR medicina”]. The open re-
pository “The Guardian Open Platform”2 was used for The Guardian,
while the open archive “la Repubblica dal 1984”3 was used for la Re-
pubblica. Articles with less than 50 characters were excluded because
they were mainly short photo-gallery or video descriptions. The initial
datasets included 195,640 articles from The Guardian and 84,849 from
la Repubblica. Starting from these initial datasets, a subset of articles
was selected using two different runs of LDA. In the first run, we ex-
tracted 50 topics for each dataset. All the topic descriptions, consisting
of the top words per topic, were then manually scrutinised in order to
select topics pertaining to the RQs: 12 relevant topics were selected in
the case of The Guardian, while 10 were chosen for la Repubblica. The
selected topics included three components: (1) explicit reference to
healthcare, disease and illness issues; (2) explicit reference to health-
care and biomedical agencies and public funding for healthcare and
biomedical research and (3) explicit reference to biomedical research
and medical technologies. Health- and medicine-related content played
a marginal role in most of the excluded topics, which were mainly
connected to other issues, such as sport, or political, economic and fi-
nancial news. Hence, the two datasets were refined to only include
articles for which one of the selected topics was most relevant (in terms
of topic proportion). In this way, through the first LDA run, the number
of articles constituting the two datasets was reduced, respectively, to
57,716 for The Guardian and 15,242 for la Repubblica. These two more
focused datasets were analysed through a second LDA run. Regarding
the first and the second run, the number of topics for extraction was set
to 50. Following the same approach adopted in the first run and using
the same three inclusion criteria, the most pertinent topics were de-
tected. Moreover, each topic was associated with the most pertinent
RQs. Table 1 provides a summary of the results of this analysis.4
The trends over time5 (year by year) of the relevant topics in the
second LDA run were computed, making it possible to observe whether
they developed according to the biomedicalization hypothesis. In order
to gain more meaningful insights with regard to our RQs, we developed
some indices (Table 2) to exploit a manually selected list of keywords.
Each index allowed a score to be assigned to each article. The score
relied on the frequency of occurrence of the keywords in the document
and a normalisation based on the length of the article.6 For example,
1 LDA is a topic model, i.e. a machine-learning technique which aims to
(footnote continued)
discover patterns of words in very large document corpora. Given a corpus as
input, a topic modelling algorithm provides as output a set of “topics”, each of
which is a group of related words, e.g. involving the same thematic issue. A
probabilistic topic model is based on the assumption that each document in a
corpus is generated by a set of topics, each of which is a probability distribution
over the entire vocabulary (the entire set of distinct words occurring in all the
documents in the corpus). See Di Maggio et al. (2013) for a discussion on topic
models in the context of social science and possible relationships with social
science theories.
2 The Guardian open archive is available at https://open-platform.
theguardian.com/. We used the option for non-commercial usage of the con-
tent. See https://open-platform.theguardian.com/access/.
3 The la Repubblica archive is available at https://ricerca.repubblica.it/.
Articles from 1984 to 2009 were collected through the la Repubblica archive.
Articles from 2010 were gathered through a platform that we designed and
developed as part of a project, which aims to implement automatic procedures
for collecting, classifying and analysing digital web content to monitor science
and technology topics.
4 All the topics and related top-five keywords selected in the second round of
LDA are detailed in Annex n. 1.
5 For each topic, we computed the proportion of the number of words asso-
ciated with (generated by) the topic in that year over the entire number of
words in all the articles published in that year (see Mimno, 2012).
6 The general formula for the index is: I(d)= 1/|W| ∑w in W TF(w,d)/B/(TF
(w,d)/B + K), where I(d) denotes the index value for document d; W is the set
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the more an article contains words such as “gene”, “genomics”, “DNA”,
“molecular”, “sequencing” and “farmacogenomics”, the more it is
supposedly related to a kind of “molecularisation”. The devised indices
were applied to topics related to RQs 1, 2 and 2.1.
The index trends were computed for a shorter period (19942017)
than those used for the topic analysis, because during the first 10 years
(1984–1993) too few articles were rendered available by the online
repositories of the two newspapers. Accordingly, the value of the in-
dices was 0 or not sufficiently reliable, being calculated on less than 10
articles per year. In this respect, we can reasonably assume that this
aspect has not significantly affected the analysis, since according to the
Clarke et al. periodization (see the Introduction) “biomedicalization
era” extends in a more substantial way starting from the mid-nineties,
with a greater intensity during the 2000s.
In order to assure a consistent base to compute the indices, a three-
year granularity was adopted. Both in the topic and index trends, the
curves often showed some peaks that depended on variations in the
number of articles and the actual oscillations in the coverage. The re-
mainder of the analysis will focus on general longitudinal trends (not on
explaining the peaks) in order to address the RQs.
3. Findings
3.1. Overview of the UK press
The longitudinal study of the topic trends (Table 3), as well as the
most relevant related-words displayed in Table 1, show the integration
of the “biomedicalization framework” in accounting health and medi-
cine narratives in The Guardian, although some ambivalences should be
considered since few trends are not confirmed by statistical sig-
nificance.7
Generally speaking, all trends pertaining to RQ1 increased during
the time frame under scrutiny, even if topic 8 trend should be regarded
carefully being not statistically significant. Hence, the most notable
change over time was the growing attention in the UK press regarding
issues explicitly addressing the “lifestylization” of well-being (topics 12,
13, 26, 28) as a socially enticing way of managing risk factors (Lemke,
2007). This aspect corroborates the assumption of Clarke and collea-
gues concerning the achievement of well-being as a task primarily
borne by the individual, whereby responsibility for maximising health
quality (traditionally linked to top-down public policies) is gradually
considered a matter of individual skills (also technologically mediated)
in the form of self-monitoring and self-surveillance. Overall, this
heightened attention in the UK press was also confirmed by the fact that
the “to be at risk index” and the “risk factors index” keep a positive
value over time (Table 4), thus suggesting that this issue maintains a
regularly coverage in the mainstream media discourse.
Looking at the indices' trends (see slope raw in Table 4), the picture
depicted by health and medicine narratives becomes more ambivalent.
Only three indices' trends are confirmed by statistical significance
(“molecularisation”, “risk” and “genetisation of risk”).8 This outlines
fluctuating trends: the attention of the media towards issues related to
biomedicalization can increase contingently due to peculiar news-
worthy events, then losing centrality with the emergence of other “hot
issues”. As clearly demonstrated by Hilgartner and Bosk (1988), cen-
trality and visibility within the media arena are achieved through a
competition process, engaging different issues that could attract the
attention of the audience. Therefore, as in the case of other cutting-edge
scientific advancements (e.g. OGMs), after an influential “hype cycle”
regarding the release of the results of the Human Genome Project (the
so-called “gene hype”, see Wehling, 2011), the molecular discourse was
gradually popularised and, thus, naturalised within the mainstream
health narratives. In this respect, as Clarke and colleagues themselves
emphasise, biomedicalization is not a ‘‘technoscientific Tsunami that
will obliterate prior practices and cultures’’ (Clarke et al., 2003, p.
184–185). They admit that the meanings and emerging practices are
negotiated in heterogeneous ways, also in media contexts, where con-
fusion, resistance and other counter social and cultural forms can
emerge or disappear from the foreground of mainstream media dis-
courses.
Table 2
List of the indices developed to analyse the content of the articles pertaining the selected topics.
Name of the Index Keywords Rationale
Molecularisation DNA, mapping, sequenc*, molecular*, genom*, proteom*,
pharmacogenomic*, gene, genetic*, genbank, genotyp*
To measure the coverage of issues concerning the integration of bio-molecular
technologies in biomedicine
Individualisation personalis*, individualis*, gene therapy, precision medicine To measure the coverage of issues concerning the development of customised
and personalised medical options
Risk risk*, danger*, hazard*, damage*; harm* To measure the coverage of issues related to risk in the context of health and
medicine
To be at risk at risk To measure the coverage of issues concerning populations and individuals at
risk of contracting problems primarily managed by biomedical science
Risk factors risk factor, risk factors, risk-factor, risk-factors, risk condition, risk
conditions
To measure the coverage of issues concerning health risk factors
Genetisation of the riska genom*, gene, genetic*, genotyp*b To measure the coverage of issues concerning the reduction of health risk
factors to the individual genome
a This index was calculated only in the articles in which the “Risk Index” was>0. The term “genetisation” can be interpreted as an adaptation of “geneticisation”,
first introduced by Lippman (1991) and later used to critically analyse the widespread tendency to define groups of people on the basis of their genetic characteristics
as well as to reduce diseases, behaviours and psychological traits as a consequence of genetic polymorphisms (see Novas and Rose, 2000; Greaves, 2000; Zinn and
McDonald, 2018). Here, “genetisation” denotes the presence of “geneticisation” as a media reference to health and illness.
b In the case of la Repubblica, there are some differences due to the linguistic specificities of the Italian language.
(footnote continued)
of keywords; TF(w,d) is the frequency of the keyword w in document d; K is a
parameter (in our analyses, it is set to 1.2); and B is a document normalisation
factor that includes the document length. This formula is based on one of the
components of the BM25 weighting scheme for ranking documents in IR (see
Robertson and Zaragoza, 2009).
7 The analysis of trends was carried out by fitting a linear regression model for
each topic and by means of the modified version of the Mann-Kendall test for
serially correlated data using the Hamed and Rao (1998) Variance Correction
approach. With regard to the former, we computed the regression line; the slope
of that line is, in the case of Tables 4 and 6, the mean increases in topic pro-
portion in 1 year. A positive value in the slope column indicates an increasing
trend, and vice versa; 0 means that trends are stable over time. R2 (i.e. coef-
ficient of determination, ranging from 0 to 1) indicates the percentage of the
(footnote continued)
variance of the variable to predict explained by the regression model. With
regard to the latter, the Mann-Kendall test is a non-parametric test for detecting
trends in time series (*p ≤ 0.05).
8 The “molecularisation index” is significant also for MK test.
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Notwithstanding this, a second remarkable change over time con-
cerned the incidence of topic 35 “Engaging lay people: the patient-
centred care” can be observed, highlighting recent actions undertaken
by the NHS towards the development of the patient-centred care ap-
proach, whose aim is “to involve patients and their carers by giving
people the power to manage their own health and make informed de-
cisions about their care and treatment and by supporting people to
improve their health and give them the best opportunity to lead the life
they want” (NHS, 2018, p. 26).
Looking at the “risk index” in The Guardian articles related to RQ2
(see Fig. 1), it results to be steadily positive, so that “risk” can be re-
garded as a relevant frame when the media discourse concerns health
and medicine focusing on technoscientific innovation. Although this
index underwent a slow but steady decline between the end of the
nineties and the first decade of the 2000s, there is a general positive
trend in the last seven years, driven mainly by a renewed interest in
“health promotion” public policies, which consider individual lifestyle
as a major risk factor. Accordingly, this implied an increase in public
policies and actions that support individuals in improving their health
and well-being through attitudinal and behavioural changes
(Tulchinsky and Varavikova, 2010). Under this perspective, and in line
with the biomedicalization hypothesis, the “invisible” work of patients
seems to assume a critical centrality, both in self-managing their own
health status and in the context of institutional clinical and care pro-
cesses, as highlighted in topic 35.
As mentioned above about the index trends in The Guardian articles
related to RQ1, media narratives informed by a “molecular gaze” did
not appear particularly pervasive (see Fig. 2). Anyway, the “molecu-
larisation index” regarding the RQ2-related articles has positive values
over time and it shows a positive trend from 2011, a crucial year for the
governance of red biotechnologies in UK, since Cancer Research UK
launched the so-called Stratified Medicine Programme for mass genetic
screening of cancers. This initiative attracted a great deal of media at-
tention regarding the expectations of genomics-based medical tech-
nologies in the form of novel and effective medical options based on
patients’ unique genetic profile (Prainsack, 2017). In this sense, even if
molecularisation and genetization doubtlessly play a relevant role in
reshaping the socio-technical meaning of biomedicalization, the extent
to which molecularisation is entangled with the promises of con-
temporary biomedicine seems to depend on the very characteristics of
overall technoscientific context. Indeed, if we focus attention on topic
trends related to RQ2, their growth over time appears reasonably co-
herent with the biomedicalization perspective: our findings show the
growing technoscientifization of biomedicine, with a major role played
by emerging systems of ICTs and nanotechnologies in transforming
biomedical landscapes and the life sciences agenda (see topic 49).
Moreover, the Guardian presented this movement as technology-driven
medicine, articulated around the emerging areas of digital technologies
with future potential, such as artificial intelligence (AI) and robotics. At
the same time, the topic labelled as “biomedical innovation” remained
stable over time, thus showing the strict traditional role of bench and
fundamental research as a form of public legitimisation of allopathic
Western medicine. The role of technoscience in reshaping biomedicine
has also affected the core of the debate about the future of the brain
Table 3
Trends (1984–2017) of health and medicine topics in The Guardian (*p ≤ 0.05).
Topic Num. Topic Label Slope R2 Trend (F test) Trend (MK test)
RQ1-Related Topics
8 War on cancer: the risky living bodies 0.0001 0.11 + +
12 Biomedical knowledge on trial: risk and lifestyle 0.001 0.53 +* +*
13 Food and life style 0.0002 0.057 + +*
26 Smoked life: tobacco related diseases 0.0003 0.46 +* +*
28 Tackling health by fitness 0.0002 0.036 + +*
35 Engaging lay people: the patient-centred care 0.0024 0.74 +* +*
RQ2- & RQ2.1-Related Topics
7 ICT and the reconfiguration of the healthcare system 0.0004 0.079 + +*
25 Biomedical innovations 0.0001 0.00046 + +*
27 The new brain sciences and the management of the mind 0.0003 0.15 +* +*
49 The future medicine: ICT, robotics, AI and nanotech 0.0003 0.15 +* +*
RQ3-Related Topics
3 Governing NHS: financial sustainability of the public hospital system −0.0004 0.12 – –
6 Private actors in healthcare −0.0002 0.01 – –
10 NGOs and charities engagement in healthcare 0.0006 0.4 +* +*
39 Governing the health care sector: private agents and the marketplace −0.0005 0.01 – –
44 Drugs design and the pharmaceutical market 0.0005 0.37 +* +*
48 Questioning the NHS: reform and governance 0.0016 0.72 +* +*
Table 4
Index trends in The Guardian articles mainly concerning RQ1 (moving average; *p ≤ 0.05).
Indices
Years Molecularisation Individualisation Risk To be at risk Risk factor Genetisation of risk
1997/1999 0,011 0,004 0,091 0,022 0,003 0,033
2000/2002 0,009 0,003 0,092 0,028 0,003 0,025
2003/2005 0,007 0,002 0,093 0,033 0,004 0,017
2006/2008 0,007 0,003 0,087 0,036 0,003 0,018
2009/2011 0,007 0,005 0,075 0,035 0,003 0,019
2012/2014 0,005 0,005 0,066 0,029 0,003 0,014
2015/2017 0,006 0,004 0,077 0,032 0,004 0,016
slope −0.0008 0.0003 −0.004 0.0012 0.0001 −0.0025
R2 0.79 0.23 0.69 0.29 0.10 0.69
test F -* + -* + + -*
test MK -* + – + + –
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sciences (topic 27), in which science-based treatments are evolving
towards a biologically based aetiology of mental disorder and the in-
jection of ICTs in managing diagnostic practices (see Orr, 2010).
Lastly, the press did not focus heavily on the commodification of the
healthcare system, thus marking a decrease over time of the topic re-
garding the role of the private sector in providing healthcare services
(topic 6). The discussion about the need to reform the public healthcare
system became relevant in terms of rationalising service delivery and as
part of new austerity measures. According to the data, NGOs and cha-
rities seem to be relevant in sustaining the overall healthcare system.
These organisations are deeply rooted in cooperative relationships be-
tween professionals, healthcare stakeholders and lay people, along with
the pharmaceutical sector (as pivotal actors in defining the drug
market, as shown in topic 44). Moreover, following Hallin et al. (2013),
Fig. 1. Risk index trend in The Guardian articles mainly related to RQ2 (1997–2017). [moving average: slope=−0.0041; R2= 0.633; test F and test Mann-Kendall
significant (p≤0.05)].
Fig. 2. Molecularisation index trend in The Guardian articles mainly related to RQ2 (1997–2017). [moving average: slope=−0.0085; R2=0.745; test F and test
Mann-Kendall significant (p≤ 0.05)].
Table 5
Historical trends (1984–2017) in health and medicine topics in la Repubblica (*p ≤ 0.05).
Topic Num. Topic Label slope R2 Trend (F test) Trend (MK test)
RQ1-Related Topics
9 Mental health and lifestyles as factor of risk in the context of molecular medicine 0.0015 0.59 +* +*
10 Health literacy at the nexus of self-responsibility and self-care −0.0006 0.065 – –
18 Wellness, beauty and body care: optimisation and new bio-politics 0.0002 0.082 + +*
23 Lifestyle choices and health risks 0.0005 0.41 +* +*
26 Wellness and alternative medicine −0.0001 0.0035 – –
36 Prevention and biological citizenship 0.001 0.76 +* +*
RQ2- & RQ2.1-Related Topics
5 Molecular oncology, genetic test and lifestyles 0.004 0.40 +* +*
19 Frontiers in healthcare: regenerative medicine, robotic surgery and rehabilitation 0 0.0002 = =
20 Living tissues: transplants and bio-banks −0.0001 0.067 – –
46 Biomedical research and genomics 0.0001 0.012 + +
RQ3-Related Topics
29 Healthcare governance and crisis of the welfare 0 0.0012 = =
40 Governance of the national health system: a matter of budget 0.0003 0.17 +* +*
F. Neresini, et al. Social Science & Medicine 243 (2019) 112621
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we see this as a form of subsumption of a competing knowledge system
– a factor considered crucial by Clarke at al. (2003, p. 177) in boosting
the biomedicalization. The process of co-optation of collectives of lay
people by institutional biomedicine has also been marked by the growth
of topic 35 concerning the definition of so-called patient-centred care,
which is one of the most relevant policy frameworks in the UK ac-
cording to the UK government White Paper “Equity and excellence:
Liberating the NHS” (2010) devoted to “create a more responsive, pa-
tient-centred NHS” (Grosios et al., 2010).
3.2. Overview of the Italian press
Concerning the Italian case, the historical trends from 1984 to 2017
regarding health- and medicine-related topics are detailed in Table 5.
The majority of trends related to RQ1 have been increasing over
time; the others are stable (topic 26) or, if decreasing, are not statisti-
cally significant, as in the case of topic 10 about health literacy. This
last suggests that when addressed directly, the role of individuals tends
to be less prominent.
Differently from what has been observed in the UK press, it is worth
noting that in the Italian case the health stylization has increasingly
been exposed to a “molecular gaze”, as demonstrated by the growing
relevance of the “molecularisation index” in the articles of most re-
levance to RQ1 (Table 6). Similarly, the relevant references to risk –
proven by the “risk index” values (Table 6) – appears to be consistent
with the analysis by Clarke et al., especially when framed as a matter of
individual concern: biomedicalizing practices imply new mandates to
be embodied into one's sense of self (Peterson and Lupton, 1996; Lemire
et al., 2008), e.g. being (pro)active and prevention-aware (see topic
23). This historical trend outlined in our evidence is also accompanied
by the growing centrality of health news, which frames patienthood
within new forms of patient activism (topic 36). This opens the space
for the formation of new forms of biosociality in which the individual
experience of health and illness can be inscribed.
Also in the Italian newspapers, individuals, or communities of
concerned people, are increasingly being called upon to enhance
themselves by eating the right foods, keeping fit, or taking a genetic test
to determine (see “molecularisation index” and “genetisation of risk
index”) disease susceptibility or potential genetic issues in their unborn
children (see Prainsack, 2017, p. 84).
All these aspects seem to be congruent with the permanent positive
values of the “individualisation”, “to be at risk” and “risk factors” in-
dices. This corroborates Zinn and McDonald (2018) affirmation that
“the health domain has been identified as one of the key social domains
where the notion of risk has become pervasive both in research as well
as public debate” (p. 37). These authors have also provided evidence to
show that there is “an increasing presence of the RISK FACTOR” and
that such a tendency “is much more prominent in the health sector than
in other social domains” (p. 144).
Table 5 shows that the rising coverage of molecular biomedicine
appears clearly in cancer-related topic (5) and in that concerning the
genomics-based medical research (46), even if this last tendency is
weakened being not statistically significant. But the general trend is
confirmed by the “molecularisation index”, which shows a slightly in-
crease in articles relating to these topics (Fig. 3). Conversely, interest in
transplantation and tissue banks (topic 20) has been decreasing. It can
be argued that there is a connection between the two trends: the space
dedicated to the second issue by the media can be replaced by the at-
tention to the first or, even better, by the promise that molecular bio-
medicine will help overcome the need for organ donations and tissue
storage.
The relevance of technoscientific innovation (topic 19) remains
stabilised over time, suggesting that emerging technologies and new
scientific discoveries are accounted as crucial elements in the devel-
opment of biomedicine.
The “risk frame” is more pervasive in RQ2-related topics (Fig. 4),
even if the trend is not particularly pronounced, and thus not statisti-
cally significant.
This can be interpreted as a substantiation of the biomedicalization
hypothesis, suggesting that media coverage of technoscientific research
in medicine is routinely related to a risk frame, both on the side of
people who are exposed to the risk of becoming ill and on the side of the
increasing commitment of medicine to the early detection of such an
event in order to impede it.
Finally, even if the attention regarding the governance of the Italian
National Health System (SSN) in the context of the welfare state crisis
(topic 29, Table 5) appears stable over time, we detected during the
first ten years of the 2000s a growing attention over SSN governance, as
a matter of budgetary concern (topic 40, Table 5). Noteworthy is the
fact that in Italy, the weak turning towards a more central role of the
private sector in the health domains is well confined within a general
discourse about the problem of the financial sustainability of the SSN,
and this is most frequently addressed in terms of regional rather that
state governance (top three keywords topic 40: region; regional; Puglia
– see Table 1). Hence, if the salience of the biomedicalization's engines
in accelerating the significance of the private sector is not so evident in
the case of Italy, this might be at least partially related to the peculiarity
of the Latin welfare system, where state still plays a prominent role in
the provision of citizen's health security and services (Raphael and
Bryant, 2015).
4. Discussion and concluding remarks
Even if the entanglement of technoscience and biomedicine in
media sphere is complex and sometimes ambivalent, we found many
specific clues drawing a trend toward the ‘‘biomedicalization of the
Table 6
Index trends in la Repubblica articles most related to RQ1 (moving average; *p ≤ 0.05).
Indices
Years Molecularisation Individualisation Risk To be at risk Risk factor Genetisation of risk
1997/1999 0.007 0.004 0.073 0.002 0.008 0.010
2000/2002 0.009 0.005 0.072 0.002 0.009 0.011
2003/2005 0.011 0.005 0.068 0.002 0.009 0.016
2006/2008 0.011 0.005 0.075 0.002 0.008 0.018
2009/2011 0.010 0.004 0.074 0.003 0.007 0.016
2012/2014 0.016 0.003 0.070 0.002 0.009 0.027
2015/2017 0.022 0.005 0.085 0.001 0.016 0.030
slope 0.0021 −0.0001 0.0014 −0.0001 0.0008 0.0033
R2 0.773 0.038 0.289 0.071 0.322 0.876
test F +* – + – + +*
test MK +* – + – + +*
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press”: on the basis of the analysis over the media coverage about
health and medicine reports in the UK and Italian press, we can argue
that the biomedicalization process has become an increasingly sig-
nificant frame. Not only does our research reveal several entangled
topics that are clearly related to this process within the mainstream
media discourse; they have also gained increasing relevance over time.
First, the paper shows that there is a relevant focus on “lifestyles”
and that individuals are supposed to act responsibly in order to cope
with the potential risks to which their health can be exposed (RQ1).
This happens mainly when media are addressing cancer-related issues,
for which the “risk factors” narrative is well established, often in terms
of “being at risk” with reference to specific epidemiological population
groups. At the same time, in accordance with the biomedicalization
thesis, the increasing importance ascribed to individuals suggests that
they cannot be relegated to the subordinate role of “patient”, to whom
it is only required to be compliant with practitioners’ prescriptions. This
is confirmed by the prominent presence of patients, their families and
organisations within the media discourse – as active subjects in
managing their own biomedicalization trajectory (see topics 10 and 35
for the UK case; and 36 and 18 for the Italian case). Differently from the
UK, in Italy, this is significantly related to alternative medicine, the
importance of which can be interpreted as a form of “interpenetration”
of the biomedicalization with other system of knowledge and expertise.
Hence, it is worth emphasising that the increasing attention by media
discourses on the individual's responsibility towards health, nudging
people to take care of their own well-being (Praisnack, 2018, p. 86),
highlight a new focus on treatment of risks and lifestyles rather than
discussing ever more diagnostic categories of illness.
Second, generally speaking, it becomes increasingly evident the
framing of biomedicine as a large technoscientific enterprise: emerging
research fields (robotics, nanotechnologies, AI) and their technological
embodiments are strongly intertwined in the media discourse about
health and medicine (RQ2 and RQ2.1). This happens both in the UK and
Italy, even if in Italy the “molecular gaze” seems to be a more promi-
nent lens to account for contemporary technologically-driven medicine.
Thus, genetics and genomics are in fact more present and shows a
slightly trend of increasing relevance in Italian media. There is, more-
over, a declining interest in transplants and tissue banks, which seems
to have been replaced by other emerging research areas, such as pre-
cision medicine. Conversely, within the UK press coverage more at-
tention has been drawn to AI, and the importance of novel biological
approach to brain sciences. At the same time, biomedicalization dis-
courses appear in general to be interested primarily in technoscientific
research with potential health outcomes and potentially relevant
translational benefits, than in basic research that has long-term bene-
fits.
Third, the transformation of healthcare systems does not seem to be
represented in the media coverage in terms of extension of the re-
sponsibilities of for-profit actors and the progressive commodification
of health; rather, it implies a prolonged public discussion on the
Fig. 3. Molecularisation index trend in La repubblica articles related to RQ2 (1997–2017). [moving average: slope=0.0010; R2= 0.110; test F and test Mann-
Kendall not significant (p≤ 0.05)].
Fig. 4. Risk index trend in La Repubblica articles mainly related to RQ2 (1997–2017). [moving average: slope=0.0013; R2=0.429; test F and test Mann-Kendall not
significant (p≤0.05)].
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governance and sustainability of national health systems, within the
general frame of the systemic crisis of the welfare state. This can be
related to the fact that mainly US represented the context of reference
for the development of the biomedicalization theory, where private
stakeholders and health insurances companies gained a pivotal role and
where the public national healthcare system is less universalistic than
in the UK and Italy, even if in US the state – together with biotech
companies – supports consistently the scientific research in the medical
field.
Starting from our evidences, we can argued that – differently from
the analysis of biomedicalization in US – the strengthening of the cor-
porate (instead of the state-funded) nature of biomedicine is mitigate by
the power of the state in devolving to public local authorities (see topic
48 in UK and 40 in Italian) and semi-autonomous regulatory bodies
(such as bioethics commissions) responsibilities for the management of
human health. Doubtless, this is a peculiarity related to the organisation
of the European welfare state, where the levers of the biomedicalization
still seem to be primarily managed by public governmental bodies (see
Raphael and Bryant, 2015). However, this does not prevent emerging
forms of bio-capital accumulation, where the capital itself is re-
organized by means of hybrid linkage with the life sciences, technolo-
gies, and institutions including the state and corporate pharmaceutical
industry (e.g. topic 44 in UK). Consequently, what is at stake in the
public discussion in these two countries tends to be the issue of ren-
dering the national healthcare system more sustainable and compatible
with non-expansionary monetary policies, as well as austerity ap-
proaches in managing state government budgets. It is not by chance,
therefore, that UK and Italian newspapers assign considerable amounts
of space to this topic. At the same time, especially in UK (see topic 10)
NGOs appear as strategic partners in the mainstream approach to bio-
medicine, working with state and regional governments under condi-
tions of “subsidiarity”.
In conclusion, this comparative research – both longitudinal and
synchronic, i.e. confronting different contexts – shows that biomedi-
calization processes appear to resonate in the media, demonstrating
that a media analysis can be useful for analysing general trends and
detecting changes in the social transformation of defining, managing
and debating health and medicine.
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